Pendrea Bio
PrivateLast Round
Grant
Dec 14, 2022
Total Funding Raised
$4.1M
Company Overview
Pendrea Bio operates in Healthcare & Life Sciences and is based in Boalsburg, Pennsylvania. Its latest recorded funding round was a Grant round in December 2022.
Pendrea Bio is a biotechnology company that develops nanotechnology platforms for the delivery of therapeutic agents, including RNA therapeutics and cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendrea Bio Comparables
Compare Pendrea Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurCan Therapeutics | 83% | |
| Duo Oncology | 79% | |
| Acuitas Therapeutics | 79% |
For institutional investors. Book with your work email.
Pendrea Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 14, 2022 | ||||
| Grant | Oct 5, 2015 | ||||
| Grant | Aug 20, 2012 |
For institutional investors. Book with your work email.
Pendrea Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ben Franklin Technology Partners of Central & Northern PA | VC Round |
| Pennsylvania Department of Health | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2022
$3K round led by Innovation Partnership
- Aug 20, 2012
Received grant from the Pennsylvania Department of Health.
For institutional investors. Book with your work email.
Pendrea Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pendrea Bio's valuation, stock price, and market status.
Is Pendrea Bio a public or private company?
Pendrea Bio is a private company.
What is the current stock price of Pendrea Bio?
Pendrea Bio is a private company, so its shares have no public market price. Caplight tracks Pendrea Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pendrea Bio worth (valuation)?
Valuation information for Pendrea Bio is not publicly available.
Can I buy Pendrea Bio stock?
Pendrea Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pendrea Bio's last funding round?
Pendrea Bio's most recent funding round was Grant on December 14, 2022.
Who are the main investors in Pendrea Bio?
Key investors in Pendrea Bio include National Cancer Institute, Pennsylvania Department of Health, National Institutes of Health (NIH).
Will Pendrea Bio IPO soon?
No public IPO plans have been announced for Pendrea Bio.
How can I track Pendrea Bio secondary market activity?
Caplight tracks bids, offers, and trades in Pendrea Bio's shares on secondary markets.